| Literature DB >> 28594841 |
Lu Zhang1,2, Lin Shi3,4, Bin Zhang1,2, Lei Zhao3, Yuhao Dong1, Jing Liu1,2, Zhouyang Lian1,2, Long Liang1,2, Wenbo Chen1, Xiaoning Luo1,2, Shufang Pei1,2, Xiaokai Mo1, Wenhui Huang1, Fusheng Ouyang1,2, Baoliang Guo1,2, Changhong Liang1, Shuixing Zhang1.
Abstract
BACKGROUND: Alterations of functional connectivity (FC) and spontaneous brain activity (SBA) during the resting state has been observed in subjects with major depressive disorder (MDD). Although there are many studies separately describing on the alterations of FC and SBA in major depressive disorder, their correlation are still have not been performed.Entities:
Mesh:
Year: 2017 PMID: 28594841 PMCID: PMC5464553 DOI: 10.1371/journal.pone.0178386
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Checklist for quality assessment of case-control studies.
| 1. Was the Case Definition Adequate? (e.g. hospital records) (if yes, one star, no star if definition was inadequate or definition was not described) |
| 2. Was the case collected consecutively and representative? (if yes, one star) |
| 3. Was the source of control group same as case group? (if yes, one star, no star if drawn from a different source or the source was not described) |
| 4. Were controls had no history of this outcome(endpoint)and definited explicitly? (if yes, one star) |
| 5. Adjustment for confounding factors? (if age- and sex-matched, one star, other important factors controlled, one star) |
| 6. Ascertainment of Exposure: any reliable document or others? (if yes, one star) |
| 7. Same method of ascertainment for cases and controls? (if yes, one star) |
| 8. Was non-response rate same in both groups? (if yes, one star) |
Assessment of included trials: low quality, 1–4 stars; high quality, 5–9 stars.
The details of parameterization for the relationship of MDD biomarkers.
| Factors | Description |
|---|---|
| Report times(T) | The number of current studies regarding the same relationship. |
| Number of MDD subjects(N) | The number of subjects clinical presented with MDD (longitudinal study) or related to a high-risk factor for MDD (cross-sectional study) |
| Correlation coefficient (r) | This coefficient denotes the degree of correlation between two biomarkers. The sign of r shows the correlation is positive (sign(r) = + 1) or negative (sign(r) = − 1). |
| Cross-sectional penalty(α) | If the study is cross-sectional, its result should bear a penalty, due to its restriction in observing the conversion in from NC (normal control) to real MDD patient. For cross-sectional study, α = 0.5; for longitudinal study, α = 1. The value of 0.5 in this penalty is determined empirically, and an alternative setting makes little difference with current findings in surveyed literatures. |
| Significance penalty(β) | This penalty is used to integrate the significance of a finding to width, where β = (0.05/p)1/2. We use 0.05 as the reference significance level and introduce the square operation to avoid extreme edge appearance. |
| Scaling coefficient (A) | This coefficient is empirically set to adjust the width of edge for best appearance. (A = 0.01) |
Fig 1Flow diagram of study selection.
Summary of the literatures surveyed.
| Number | Study ID | Number (CN: pAD) | Mean age (CN: pAD) | Medication | Primary analysis method |
|---|---|---|---|---|---|
| (1) | [ | 38:38 | 32:30 | No | Seed-FC |
| (2) | [ | 22:19 | 28:24 | No | NH(fALFF) |
| (3) | [ | 41:29 | 15:16 | Partly | Seed-FC (amygdala) |
| (4) | [ | 24:24 | 25:24 | No | NH |
| (5) | [ | 17:17 | 26:24 | No | NH(ReHo) |
| (6) | [ | 49:68 | 36:35 | Partly | NH(ALFF /fALFF) |
| (7) | [ | 16:16 | 34:33 | No | Seed-FC (insula) |
| (8) | [ | 11:18 | 71:64 | Partly | Seed-FC(Cerebellar) |
| (9) | [ | 17:20 | 19:19 | No | NH(fALFF) |
| (10) | [ | 15:16 | 15:13 | No | NH(ALFF) |
| (11) | [ | 44:44 | 28:29 | No | NH(fALFF) |
| (12) | [ | 16:16 | 34:33 | No | NH(ReHo) |
| (13) | [ | 15:15 | 29:30 | Partly | NH(ReHo) |
| (14) | [ | 21:18 | 9:9 | No | Seed-FC(whole-brain) |
| (15) | [ | 42:30 | 29:26 | No | Seed-FC (hippocampus) |
| (16) | [ | 24:24 | 25:24 | No | NH(fALFF) |
| (17) | [ | 37:37 | 20:20 | No | Seed-FC |
| (18) | [ | 32:35 | 20:20 | No | Seed-FC |
| (19) | [ | 37:14 | 9:8 | No | Seed-FC (amgydala) |
| (20) | [ | 23:20 | 33:31 | Partly | Seed-FC (whole-brain) |
| (21) | [ | 21:21 | 37:38 | No | Seed-FC (whole-brain) |
| (22) | [ | 18:17 | 35:30 | No | Seed-FC |
| (23) | [ | 44:27 | 36:38 | No | NH(fALFF) |
| (24) | [ | 7:9 | 70:68 | No | Seed-FC |
| (25) | [ | 14:14 | 32:34 | No | NH(ReHo) |
| (26) | [ | 16:14 | 34:30 | No | Seed-FC (whole-brain) |
| (27) | [ | 24:24 | 25:24 | No | Seed-FC |
| (28) | [ | 20:20 | 38:33 | No | Seed-FC |
| (29) | [ | 15:15 | 67:64 | No | NH(ReHo) |
| (30) | [ | 19:18 | 66:66 | Partly | NH(ReHo) |
Note: HC, healthy controls; ReHo, regional homogeneity; (f) ALFF, (fractional) amplitude of low frequency fluctuations; VMHC, voxel-mirrored homotopic connectivity; ICA, independent component analysis; NH, network homogeneity. All studies are cross-sectional and only the data with p < 0.05 was selected.
Fig 2The Probabilistic Entity-Relationship Diagram of MDD.
Each point refers to the rs-FC of the brain and the color of each point refers to different categories. Edge widths refer to the degree of consensus on a certain correlation and the color of edge widths refer to the sign and strength of the correlation. (a) The PERD of MDD-A represent rest-stating functional connectivity. (b) The PERD of MDD-B represent spontaneous brain activity. (c) The PERD of MDD represent a combination of them.
Detailed intra-network of studies included in the meta-analysis.
| NH (ALFF/fALFF/ReHo) | Seed-FC | |||
|---|---|---|---|---|
| Regions | Increase | Decrease | Increase | Decrease |
| cere.P. lobe | (2,5,9,12,13,29) | |||
| cere.A. lobe | (25) | |||
| Parahip | (2,5,9, 16) | (3) | ||
| Hip | (26, 27) | (3) | ||
| Brainstem | (3) | |||
| OFC | (18,30) | (3) | ||
| Precuneus | (9,13,29) | (3, 20) | ||
| L. dmPFC | (4,16, 25) | (8, 22) | ||
| R. dmPFC | (22) | (8, 28) | ||
| ITG | (10) | (4,9,24,29) | (27) | |
| R.fusiform | (9, 10) | (4) | ||
| L. fusiform | (18) | (8) | ||
| PCG | (5, 13, 29, 30) | (23) | ||
| AI | (6) | (20) | ||
| Lingual | (9) | (6) | ||
| DLPFC | (9,29,30) | (20) | (8, 27) | |
| L.IFG | (9,13) | |||
| L.IPG | (13) | (27) | ||
| MC | (9,29) | |||
| PCC | (10) | (9) | (26, 28) | |
| ACC | (20) | |||
| R. SMG | (9) | |||
| R.STG | (10) | (28) | ||
| L.STG | (13, 29) | (28) | ||
| L.SOG | (2) | |||
| Insula | (10,18,30) | (13) | ||
| PG | (10) | (25) | ||
| FG | (2, 23, 25) | |||
| OG | (10,11,12,25) | |||
| TG | (18) | (12) | (23) | (3) |
| MFG | (10,11,13,30) | |||
| MPFC | (29) | (26) | ||
| L.tha | (12) | |||
| AMC | (17) | |||
| PMC | (17) | |||
| Amygdala | (13, 29) | (19) | ||
| Ven.stri | (26) | |||
Abbreviations: L/R: left;/right; I/S: inferior/superior; M: medial; A/P: anterior/posterior; DL: dorsolateral; dm: dorsal medial; OG: occipital gyrus; PG: parietal gyrus; FG: frontal gyrus; TG: temporal gyrus; PFC: prefrontal cortex; hip: hippocampal; tha: thalamus; cereb. tonsil: cerebellar tonsil; cere: cerebellum; PCG: postcentral gyrus; MC: motor cortex; SMG: supramarginal gyrus; BA10p: included the ventromedial PFC, dorsal ACC, superior frontal gyrus, PCC, precuneus and angular gyrus, subcortical regions, the thalamus, caudate, and putamen; BA25: subcallosal cortex, frontal pole; Ven.stri: ventral striatum
Detailed between-nework of studies included in the meta-analysis.
| Regions | (1) | (7) | (14) | (15) | (21) | (24) |
|---|---|---|---|---|---|---|
| PCC -dmPFC | − | |||||
| PCC-R.IPG | − | |||||
| L.tha-cereb.tonsil | − | |||||
| Insula- dmPFC | − | |||||
| Insula- pulvinar | − | |||||
| PCC-MTG | − | |||||
| PCC-IPG | − | |||||
| PCC-cere | − | |||||
| PCC-ACC | + | |||||
| R.hip-R.ITG | − | |||||
| R.hip- cere | − | |||||
| BA10p-R. Iinsula | − | |||||
| BA25-ACC | − | |||||
| rAI-dACC | − | |||||
| rAI-SN | − | |||||
| rAI-R.dlPFC | + | |||||
| rAI-R.PCC | + |